CANESTEN owner Contact Information online
from Bayer Aktiengesellschaft
CANESTEN
US serial number:85162120
Application filling date:Oct. 27, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jun. 09, 2014
Publication date:Mar. 08, 2011
Abandoned date:Jun. 09, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: antimycotic drugs
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:antimycotic drugs
Current owner owner name:Bayer Aktiengesellschaft
Current owner owner address:Kaiser-Wilhelm-Allee
51373 Leverkusen
GERMANY
Current owner legal entity type:aktiengesellschaft
Current owner state or country:GERMANY
Attorney name:Jeffrey M. Gitchel
Attorney email:BayerTrademarkUS@Bayer.com
Attorney email authorized:Yes
Correspondent name address:Jeffrey M. Gitchel
Bayer Corporation
100 Bayer Road
Pittsburgh,
PENNSYLVANIA
UNITED STATES
15205
Correspondent phone:412-777-4860
Correspondent email:BayerTrademarkUS@Bayer.com
Correspondent fax:412-778-4432
Correspondent email authorized:Yes
Domestic representative name:Jeffrey M. Gitchel
Domestic representative phone:412-777-4860
Domestic representative fax:412-778-4432
Domestic representative email:BayerTrademarkUS@Bayer.com
Domestic representative email authorized:Yes
Trademark staff tm attorney:BEVERLY, JOSETTE MICHE
Trademark staff law office assigned CANESTEN:LAW OFFICE 115
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (131) JOHNSON & JOHNSON (125) Bayer Aktiengesellschaft (57) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Bristol-Myers Squibb Company (34) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Apr. 19, 2011 Mar. 29, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
